NZ616754B2 - High barrier elastomer fecal catheter or ostomy pouch - Google Patents

High barrier elastomer fecal catheter or ostomy pouch Download PDF

Info

Publication number
NZ616754B2
NZ616754B2 NZ616754A NZ61675412A NZ616754B2 NZ 616754 B2 NZ616754 B2 NZ 616754B2 NZ 616754 A NZ616754 A NZ 616754A NZ 61675412 A NZ61675412 A NZ 61675412A NZ 616754 B2 NZ616754 B2 NZ 616754B2
Authority
NZ
New Zealand
Prior art keywords
catheter
fecal
fecal catheter
styrene
silicone
Prior art date
Application number
NZ616754A
Other versions
NZ616754A (en
Inventor
Tinh Nguyendemary
Mingliang Lawrence Tsai
Original Assignee
Convatec Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Convatec Technologies Inc filed Critical Convatec Technologies Inc
Priority to NZ712149A priority Critical patent/NZ712149B2/en
Priority claimed from PCT/US2012/029375 external-priority patent/WO2013043226A1/en
Publication of NZ616754A publication Critical patent/NZ616754A/en
Publication of NZ616754B2 publication Critical patent/NZ616754B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/44Devices worn by the patient for reception of urine, faeces, catamenial or other discharge; Portable urination aids; Colostomy devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/44Devices worn by the patient for reception of urine, faeces, catamenial or other discharge; Portable urination aids; Colostomy devices
    • A61F5/441Devices worn by the patient for reception of urine, faeces, catamenial or other discharge; Portable urination aids; Colostomy devices having venting or deodorant means, e.g. filters ; having antiseptic means, e.g. bacterial barriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/44Devices worn by the patient for reception of urine, faeces, catamenial or other discharge; Portable urination aids; Colostomy devices
    • A61F5/445Colostomy, ileostomy or urethrostomy devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64Animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/04Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L28/00Materials for colostomy devices
    • A61L28/0007Materials for colostomy devices containing macromolecular materials
    • A61L28/0026Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L28/00Materials for colostomy devices
    • A61L28/003Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L28/00Materials for colostomy devices
    • A61L28/0061Materials for coating
    • A61L28/0069Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L28/00Materials for colostomy devices
    • A61L28/0073Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L28/008Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
    • A61L28/0092Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing inorganic fillers not covered by groups A61L28/0084 or A61L28/0088
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/02Inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04Macromolecular materials
    • A61L29/049Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • A61L29/085Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L29/126Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions

Abstract

Disclosed are fecal catheters made of an odor barrier material comprising; a thermoplastic elastomer selected from the group consisting of a styrenic block copolymer, a thermoplastic vulcanizate, or a polyolefin elastomer; an odor barrier modifier selected from polyisobutene, polybutene, or an organoclay; and an antiblocking agent selected from the group consisting of essentially inorganic fillers, including silica, talc, clay, and mica; wherein the fecal cathether comprises a surface having an arithmetic mean surface roughness (Ra) not less than 0.1 micron. oclay; and an antiblocking agent selected from the group consisting of essentially inorganic fillers, including silica, talc, clay, and mica; wherein the fecal cathether comprises a surface having an arithmetic mean surface roughness (Ra) not less than 0.1 micron.

Description

HIGH BARRIER ELASTOMER FECAL CATHETER OF OSTOMY POUCH FIELD OF THE INVENTION The present invention relates to an odor barrier material for a fecal catheter, a fecal pouch, or an ostomy pouch.
BACKGROUND OF THE INVENTION Fecal catheters have occasionally been criticized for the transmission of fecal odor through the tubular walls.
A possible cause of the poor odor barrier is the silicone material of which these devices are composed. The odor barrier of silicone is known to be one of the worst among r materials. For example, the oxygen transmission rate of silicone has been reported to be 775,000 cc mil/mZ/day. Therefore, a 20 mil thick silicone catheter is about 3 orders of magnitude worse than a commonly used ostomy film having a transmission rate of 50 day or less.
Another possible explanation for silicone fecal catheter having poor odor barrier is that the extruded ne utilized in such devices is vely rough and as a result could trap fecal components. The contours of the spots trapping the fecal material provide ntial surface area, through which odor is transmitted.
The combination of high odor transmission rate and large surface area contributes to the poor odor barrier teristics of the silicone used in fecal catheters.
It would be desirable to develop a material to be used in a fecal catheter that has the desirable teristics of silicone while providing an odor barrier substantially better than that of silicone.
It would be ble to provide an odor barrier polymer having these characteristics.
The sion of the background to the invention included herein including reference to documents, acts, materials, s, articles and the like is included to explain the context of the present invention. This is not to be taken as an admission or a suggestion that any of the material referred to was published, known or part of the common general knowledge in New Zealand or in any other y as at the priority date of any of the claims.
SUMMARY OF INVENTION Viewed from one aspect of the present invention, there is provided a fecal catheter made of an odor r material, the fecal catheter comprising: i) a thermoplastic elastomer selected from a group including a styrenic block copolymer, a thermoplastic vulcanizate, and a polyolefin mer; ii) an odor r modifier selected from polyisobutene, polybutene, and an organoclay; and iii) an antiblocking agent selected from a group of essentially inorganic fillers, including silica, talc, clay, and mica, and wherein the fecal catheter comprises a surface having an arithmetric mean surface roughness (Ra) not less than 0.1 pm.
DESCRIPTION OF THE INVENTION Thermoplastic elastomer (TPE) or curable elastomer is well known for use in medical devices. r, these elastomers are not known to exhibit high odor barrier properties. The present invention is the modification of elastomer to achieve a high odor barrier while maintaining its softness, ability for post ion converting ng and bonding) and non-blocking characteristics.
One embodiment of the present invention related to single layer of catheter made from a high barrier elastomer such that the odor barrier measured by oxygen ission rate per ASTM D3985 is not more than 50,000 cc mil/m2/day at 23°C, or more preferably not more than 5,000 cc mil/mZ/day. Such a catheter is at least 10 times better in odor barrier than the silicone catheter.
US. Pat. No. 6,946,522, 7,056,971, and 7,060,753 disclosed the use of a liquid polyisobutene oil plasticizer to improve the gas barrier of the TPE. However, these formulations, especially when targeting a soft mer, i.e., Shore A less than 60, s a blocking issue in which the surface of TPE catheter seals against each other upon folding and packaging. The use of a higher amount of oil plasticizer would allow a softer TPE, but it comes with an e effect in an oily surface, resulting in poor post-extrusion converting (welding and bonding). in addition, the TPE based on an olefin block copolymer (OBC, such as InfuseTM made by Dow) was not sed. gh common approaches exist to minimize the blocking, including adding mineral oil or slip additives. These approaches; however, have drawbacks in that they prevent the parts from being further converted into a fecal catheter due to their adverse effects on the surface bonding. U.S. Pat. No. 406 disclosed the use of an organoclay at a concentration less than 4% to improve the barrier properties of high density hyelene (HDPE). However, the use of organoclay in a TPE was not mentioned with a Shore A ss not more than 60, or preferably not more than 50. r embodiment of the present invention is related to a fecal catheter, having a Shore A hardness not more than 60 and an oxygen transmission rate not more than 2,500 cc/mZ/day or preferably not more than 1,000 cc/m2/day, comprising (1) a thermoplastic elastomer, (2) odor barrier modifier, and (3) an antiblocking agent of at least 0.1%, wherein thermoplastic elastomer is selected from the group consisting of a styrenic block copolymer, a thermoplastic vulcanizate, or a polyolefin elastomer, and n odor barrier modifier is selected from the group consisting of polyisobutene, polybutene, or an organoclay, and wherein the antiblocking agent is ed from the group consisting of an essentially inorganic fillers, such as , talc, clay, mica, etc. and blends thereof. It is noted organoclays can be used in one embodiment as both the odor barrier modifier and as the antiblocking agent.
Organoclays include montmorillonite clay, smectite clay, intercalated clay, nanoclay, or a mixture of above. Organoclay described in this invention includes montmorillonite clay, made by Nanocor, which is the most common member of the smectite clay family. Organoclay may consist of ay with a unique morphology such that one ion is in the nanometer range. in addition, organoclay is preferred to be intercalated with an organic intercaiant resulting in a clay-chemical complex wherein the clay gallery spacing has increased due to the process of surface modification. Under the proper conditions of temperature and shear, an intercalate is capable of exfoliating in a resin matrix. Optionally, the following additives can be used to facilitate the manufacturing of er extrusion, including melt ity modifier, tackifier, detackifier, plasticizer, etc.
Styrenic block copolymer (880) based thermoplastic elastomer includes e-isoprene-styrene (SIS), styrene-butadiene-styrene (SBS), styrene— etheylene/butylene-styrene (SEBS), e—etheylene/propylene-styrene (SEPS), and blends thereof. Thermoplastic vulcanizate (TPV) includes a blend of curable rubber and a polyolefin (i.e., PP or PE, homopolymers and copolymers). Curable rubbers include EPDM, EP rubber, santoprene, etc. A polyolefin elastomer includes an olefin block copolymer (080), such as infuse made by Dow, where a crystalline phase of a olefin block copolymer acted as hard blocks, and the amorphous block copolymer acted as soft blocks within the same polymer . The following is a summary of odor barrier as measured by oxygen transmission rate at 23°C per ASTM D3985: Table 1 - Odor Barrier Comparison of s Eiastomers t Organoclays or zeolites Silicone i SBC _“‘ TPV osc sec w/ sac w/ polyisobute polyisobutene ne and clay W0-7,500 i 3 4 2,500 1,000 250 cc/mZ/day, 4,500 mil thick wail, ASTM D3985 Onion Very poor, Poor, Poor, Poor, Better, God, not Barrier, detectable detectable detectable detectable detectable detectable for 8 ISO 8670-3 in 10 in 60 in 60 in 60 in 120 hrs minutes s minutes minutes minutes When antiblocking agent, at least 0.1% or more preferably more than 0.5%, was added to a high barrier elastomer formulation containing a SBC thermoplastic elastomer and a liquid polyisobutene, an odor barrier in the range of around 1000 cc/mZ/day was achieved for making a non-blocking fecal catheter. This level of odor barrier improvement was confirmed by an onion test per lSO 8670-3 such that the onion odor breakthrough was longer than 120 minutes. Additional barrier ement was seen in fecal catheter made from PTE containing a SBC thermoplastic elastomer, a liquid polyisobutene, an organoclay. In this example, onion odor breakthrough was longer than 8 hours. The results of both oxygen barrier and onion barrier were shown in Table 1.
Another embodiment of the present invention is a fecal er based on a multilayer structure, wherein at least one layer is selected from a high barrier elastomer described above without any antiblocking agent, and at least another skin layer is selected from the group ting of (1) same high barrier elastomer bed above with at least 0.1% of antiblocking agent, or an elastomer alloy with or without the use of antiblocking agent. An elastomer alloy is defined as a blend of two polymer matrixes which are incompatible in a lar level. The advantage of ocking agent is to impart a rough surface so that the catheter is not blocking.
The advantage of an elastomer alloy is that the incompatibility in a molecular level s a roughness on the catheter surface, giving rise to a non-blocking catheter.
In addition, common materials to add for an elastomer alloy include, but not limited to, plastic polyurethane (TPU). Due to a more polar structure in TPU, the subsequent converting of an elastomer alloy is easier. Since the majority of the catheter structure is ed by a high barrier elastomer, the odor barrier and the softness is maintained based on the disclosure above. Because both the center layer and the skin layer are elastomers based, the adhesion between the layers of a fecal catheter is sufficiently good.
Besides the addition of anti-blocking agent, cold processing ions can be 3O utilized to enhance a rough surface of the catheter wall so that the catheter is not blocking. The effect of anti-blocking agent and/or cold processing conditions is a rough surface that could be characterized by surface roughness using a non-contact e structure analyzer, such as Scanning White Light interferomtry , Atomic Force Microscopy (AFM), etc. A non-contact imaging surface structure analyzer based on SWLl is made by Zygo NewView 7300. A non-contact atomic force microscopy can be made by FEl. A typical parameter that has been used to quantify the quality of a surface topography is the surface roughness, which is represented by the arithmetic mean value, Ra. in this invention disclosure, a rough surface with Ra not less than 0.1 pm or ably not less than 1 pm when antiblocking agent is used with or without a cold processing temperature, resulted in a non-blocking fecal catheter.
An important characteristic about the formulation described in this invention is its ability to be post—extrusion converted, both by welding and adhesive bonding.
Greater than 5 N/in adhesive strength and heat weld strength was achieved.
Another embodiment of the present ion is related to the use of clays and/or zeolites to improve the odor barrier of the mer catheter.
For example, a single layer of catheter can be made from an organoclay-containing mer selected from the group consisting of silicone, polyurethane, styrenlc block copolymer, thermoplastic vulcanizate, or polyolefin elastomer with a Shore A hardness not more than 60, or more preferably not more than 50.
The use of nanocomposite (nanoclays) fillers to improve the odor barrier is not new. The addition of nanocomposite fillers s the tortuous path for the odor causing compounds; thus improving the odor barrier for the substrate. There are various nanocomposite containing coating, additives, or polymers marketed by various companies, such as Nanocor, Nanoresin, rn Clays, , lnmat, etc. Since nanocomposites are mostly clay based, it is relatively rigid. Therefore, the challenges of using nanocomposite fillers in FMS application are two fold, (1) the difficulty in the wetting and adhesion of the nanocomposite fillers or coating onto the silicone tubing, and (2) the odor barrier property upon flexing. ore, the uniqueness of this invention is the formulation of a soft tube with a completely covered, and/or relatively uniformly dispersed mposite containing catheter which would not crack upon flexing. Such a soft nanoclay—containing catheter is characterized with a Shore A hardness not more than 60, or more preferably not more than 50.
Another embodiment of the present invention is related to single layer of catheter made from a zeolite-containing elastomer selected from the group ting of silicone, ethane, styrenic block copolymer, plastic vulcanizate, or efin mer with a Shore A hardness not more than 60, or more ably not more than 50.
The addition of zeolite creates the tortuous paths and sites to adsorb the odor causing compounds; thus improving the odor barrier for the substrate. There are various zeolites marketed by various companies, such as UOP. Since zeolites are hard fillers, they produce rigidity when used. Therefore, the challenges of using es in FMS application are two fold, (1) the difficulty in the g and adhesion of the zeolite coating onto the silicone tubing, and (2) the odor barrier property upon flexing. Therefore, the uniqueness of this invention is the formulation of a soft tube with relatively uniform zeolite-containing elastomeric catheter which would not crack upon flexing. Such a soft zeolite-containing catheter is characterized with a Shore A hardness not more than 60, or more preferably not more than 50.
Another embodiment of the present invention is related to an organoclay— containing coating onto an elastomer substrate selected from the group consisting of silicone, polyurethane, styrenic block copolymer, thermoplastic vulcanizate, or polyolefin elastomer with a Shore A ss not more than 60, or more ably not more than 50.
Another embodiment of the t invention is related to a zeolite-containing g onto an elastomer substrate selected from the group consisting of silicone, polyurethane, styrenic block copolymer, thermoplastic vulcanizate, or polyolefin elastomer with a Shore A hardness not more than 60, or more preferably not more than 50.
A series of experiments were conducted as described below. A total of four different nanocomposites were evaluated, two from Southern Clay and two from Nanocor. Two types of coating matrix were used, silicone and polyurethane. The ing is a summary of these findings: Exg. #1: Silicone coating consisting of nanocomgosites: 2.5% of the following nanocomposites were added into a two-part silicone made by Nusil 6350, including (1) Southern Clay Cloisite Na+, Hydrated Aluminum Silicate, (2) Southern Clay Cloisite 15A, Ammonium salts with ite, (3) r 1.30E (Octadecyl ammonium surface compatabllized montmorillonite), and (4) Nanocor 1.34 TCN (methyl, bis hydroxyethyl octadecyl ammonium surface compatabilized montmorillonite).
The two-part silicone was applied onto the silicone catheter as a coating, and was then heat cured at 130 deg C for 30 minutes. The coated catheter was then tested for onion odor barrier per ISO 8670-3:2000. About 5 grams of onion was d and filled inside a 12 cm long coated silicone tubing (i.e., catheter). [flocomposite None Cloisite TCloisite 1 r Nanocor NA+ 15A 1.30E 1.34TCN Coating Matrix, Silicone Silicone Silicone Silicone Silicone Nusil 6350 Substrate, Silicone Silicone Silicone ne Silicone Dow Corning C6-l35 Onset of Onion Smell l 5 minutes 45 minutes 45 minutes 90 minutes 60 minutes As can be seen, the on of 2.5% nanocomposites in a silicone coating improves the onion odor barrier in the silicone tubing. The control with a silicone coating had an onset of onion odor outside of the closed silicone tubing at around 5 minutes. This is about the same as the silicone tube without any coating. After a silicone coating ting of 2.5% nanocomposites was applied onto a silicone tube, the onset of the onion odor was extended to 45 — 90 minutes.
Exp. #22Polyurethane coating consisting of nanocomposites, t primer: 2.5% of the following nanocomposites were added into a two—part polyurethane made by Smooth-On, Vytaflex 30, including (1) Southern Clay Cloisite Na+, ed Aluminum Silicate, (2) Southern Clay Cloisite 15A, Ammonium salts with Bentonite, (3) Nanocor 1.30E ecyl ammonium surface compatabilized montmorillonite), and (4) Nanocor 1.34TCN (methyl, bis hydroxyethyl octadecyl ammonium e compatabilized montmorillonite).
The two-part polyurethane was applied onto the silicone catheter as a coating, and was then room ature cured for 6 hours. The coated catheter was then tested for onion odor barrier per ISO 322000. About 5 grams of onion was chopped and filled inside a 12 cm long coated silicone tubing (i.e., catheter). mposite None Cloisite IflCloisite 15A Nanocor Nanocor NA+ 1.3013 1.34TCN Coating Matrix, Polyurethane [ Polyurethane Polyurethane Polyurethane Polyurethane x 30 l ‘4 1 —_1 Primer, No No No No No Dow Corning 1200 J d _ Substrate, Silicone ne Silicone Silicone Silicone Dow Corning C6- 135 l Onset of Onion 30 minutes 6 hours 6 hours > 12 hours > 12 hours Smell i As can be seen, the addition of 2.5% nanocomposites significantly improves the onion odor barrier. The control with a polyurethane coating, but without any nanocomposites, was able to extend the onset of onion odor outside of the closed silicone tubing from 5 minutes to 30 s. After a polyurethane coating consisting of 2.5% nanocomposites was applied onto a silicone tube, the onset of the onion odor was extended to 6 — 12 hours. Despite of the odor barrier improvement, the coating adhesion was poor.
Exp. #3: Polyurethane g consisting of nanocomposites, with primer: The same set of experiment as Exp. #2 was repeated with the use of a silane primer, Dow Coming 1200. The same level of onion odor improvement was observed. That is, after a polyurethane coating consisting of 2.5% nanocomposites was applied onto a silicone tube primed with a silane, the onset of the onion odor was extended from 30 minutes in the control without any nanocomposites to 6 — 12 hours. The polyurethane coating stuck well to the silicone tube. and was able to resist the flex.
Nanocornposite None Cloisite Cloisite 15A Nanocor Nanocor NA+ 1.3013 1.34TCN g Matrix, 4! Polyurethane Polyurethane Polyurethane Polyurethanel Polyurethane LVytaflex 30 r Primer, Yes Yes Yes Yes Yes Dow Coming 1200 Substrate, Silicone rSilicone T Silicone Silicone Silicone Dow Corning C6— Panet of Onion W s 6.5 hours 6 hours > 12 hours > 12 hours j Smell Ex . #4: Nanocom osites in a silicone slab: 2% of Nanocor 1.30E was added to make into a 1 mm thick (Le, 40 mil) silicone gel slab, Nusil 6350. Onion barrier was compared on silicone slab with and without the nanocomposite per ISO 8670-3:2000. 1 mm thick silicone slab without 1 mm thick silicone slab with nanocomposites (control) 2% Nanocor 1.3013 Onset of Onion Smell 5 - 10 minutes ‘ 60 minutes As a result, the addition of 2% of r 1.30E improved the onion odor r of the silicone slab from 5 s to about 60 minutes.
Another embodiment of the present ion is an improved odor barrier fecal catheter, having a Hardness of less than Shore A 60, comprising at least (a) one layer of a silane coupling agent, and (b) at least one layer of nanocomposite coating.
This formulation, when applied onto a silicone fecal catheter, would result in an oxygen transmission rate no more than 20,000 cc/m2/day, or preferably, no more than 10,000 cc//m2/day, or more preferably no more than 5,000 cc/mZ/day. A silicone tube without the use of silane coupling agent and without the nanocomposite coating has an oxygen permeation rate of around 37,500 cc/m2/day. A silicone with the nanocomposite coating, but without the silane coupling agent, has an oxygen tion rate of close to 30,000 —- 35,000 cc/m2/day due to the lack of bonding.
Alternatively, the same formulation can be d onto a thermoplastic elastomer (TPE) or a polyurethane tubing (PU), having a Hardness of less than Shore A 60, such that the gas barrier is improved to no more than 25,000 cc/m2/day, or preferably, no more than 10,000 cc/m2/day, or more preferably no more than 5,000 day.
The materials described in this invention can be used as a fecal catheter. A fecal pouch is commonly connected to a fecal catheter in use. The same materials described for fecal catheter were used to make a fecal pouch. Similar odor barrier characteristics against oxygen transmission and onion odor shown in Table 1 were obtained in the lab. Thus, besides a fecal catheter, the same al construction could be used for an ostomy pouch.

Claims (11)

The claims defining the invention are as follows:
1. A fecal catheter made of an odor barrier al, the fecal catheter comprising: i) a thermoplastic elastomer selected from a group including a styrenic block copolymer, a thermoplastic vulcanizate, and a polyolefin elastomer; ii) an odor barrier modifier selected from polyisobutene, polybutene, or an organoclay; and iii) an antiblocking agent selected from a group of essentially inorganic fillers, ing silica, talc, clay, and mica, and 10 wherein the fecal catheter comprises a surface having an arithmetric mean surface roughness (Ra) not less than 0.1 pm.
2. The fecal catheter of claim 1 wherein the styrenic block copolymer includes styrene-isoprene-styrene (SIS), styrene-butadiene-styrene (SBS), styrene- etheylene/butylene-styrene (SEBS), styrene-etheylene/propylene-styrene (SEPS), or 15 a blend thereof.
3. The fecal catheter of claim 1 or 2 wherein the thermoplastic vulcanizate includes a blend of e rubber and a polyolefin.
4. The fecal catheter of claim 3 wherein said efin is polyethylene and polypropylene, including homopolymers and mers thereof. 20
5. The fecal catheter of claim 3 or 4 wherein the curable rubber is ed a group including ethylene propylene diene Monomer (EPDM), ethylene propylene rubber, and santoprene and blends thereof.
6. The fecal catheter of any one of claims 1 to 5 wherein the polyolefin elastomer includes an olefin block copolymer n a crystalline phase of olefin block 25 mer acts as hard blocks and an amorphous block copolymer acts as soft blocks.
7. The fecal catheter of any one of claims 1 to 6 n the clay includes montmorillonite clay, smectite clay, intercalated clay, nanoclay, or a e thereof.
8. The fecal catheter of any one of claims 1 to 7 wherein the oxygen barrier transmission rate per ASTM D3985 is 1000 cc/m2/day or less at 23C.
9. The fecal catheter of any one of claims 1 to 8 having a Shore A hardness of 60 or less.
10. The fecal catheter of any one of claims 1 to 9 wherein the surface of the fecal catheter can be bonded with an adhesive having an adhesive strength greater than 5 Win. 10
11. The fecal catheter of any one of claims 1 to 10 wherein the surface of the fecal catheter can be heat welded having a weld strength greater than 5 Win.
NZ616754A 2011-03-17 2012-03-16 High barrier elastomer fecal catheter or ostomy pouch NZ616754B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ712149A NZ712149B2 (en) 2011-03-17 2012-03-16 High barrier elastomer fecal catheter or ostomy pouch

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161453667P 2011-03-17 2011-03-17
US61/453,667 2011-03-17
PCT/US2012/029375 WO2013043226A1 (en) 2011-03-17 2012-03-16 High barrier elastomer fecal catheter of ostomy pouch

Publications (2)

Publication Number Publication Date
NZ616754A NZ616754A (en) 2015-10-30
NZ616754B2 true NZ616754B2 (en) 2016-02-02

Family

ID=

Similar Documents

Publication Publication Date Title
US11806270B2 (en) High barrier elastomer fecal catheter or ostomy pouch
RU2571692C2 (en) Water vapour-impermeable flexible tube for packing purposes
JP2013523992A (en) Method for improving the effectiveness of antibacterial agents in polymer films
ES2786314T3 (en) Asymmetric multi-layer film for an ostomy application
EP3326793B1 (en) Method for manufacturing pneumatic tires
US20100233400A1 (en) Tube for fluid transportation
EP1025864A2 (en) Medical adhesive tape or sheet, and first-aid adhesive tape
JP2010100675A (en) Composition for inner liner of pneumatic tire, and the inner liner of pneumatic tire
JP2008025623A (en) Tube for fluid transportation
KR102221276B1 (en) Strong polyolefin-based thermoplastic elastomeric films and methods of making
JP2006335997A (en) Composition for earthquake-resistant mat and the earthquake-resistant mat
NZ616754B2 (en) High barrier elastomer fecal catheter or ostomy pouch
NZ712149B2 (en) High barrier elastomer fecal catheter or ostomy pouch
JP3952192B2 (en) Damping composition
JP2001302857A (en) Resin composition having rapid stress relaxation, and molding of the resin composition
JP4778269B2 (en) Fluid transport tube
JP2004034445A (en) Multi-layer molded product
JPH0827354A (en) Elastomer composition excellent in creep characteristic
JP2008020054A (en) Fluid transporting tube and manufacturing method